Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 700-536-1 | CAS number: 25628-08-4
Endpoint summary
Administrative data
Description of key information
There are no data available for Tetraethylammonium perfluorobutanesulfonate.
Key value for chemical safety assessment
Additional information
There are no data available for Tetraethylammoniumperfluorobutanesulfonate.
A 28 d and a 90 d oral toxicity study in rats oral with potassium perfluorobutane sulfonate was evaluated and cited in the Existing Chemical Hazard Assessment Report by the Australian Government, Department of Health and aeging, NICNAS, November 2005.
In the 28 d study a No Observed Effect Level (NOEL) was established as 100 mg PFBS/kg bw/day in males in this study based on significant decreases in serum phosphorus and potassium at doses of 300 and 900 mg/kg bw/day when compared to controls. A No Observed Adverse Effect Level (NOAEL) was established as 300 mg PFBS/kg bw/day in females and males in this study based on significant increase in kidney and liver weights, respectively, in animals that received 900 mg/kg bw/day compared to controls.
In the 90 d study he NOAEL in rats was established as 200 mg PFBS/kg bw/day in this study based on necrosis in the limiting ridge of the forestomach. A significant (p = 0.05) decrease in average total protein and albumin values of 7% and 10%, respectively, was seen in males, and a significant (p = 0.01) increase in serum chloride was seen in the males. Kidney hyperplasia was also reported at 600 mg PFBS/kg bw/day. However, histopathological of the kidney by an independent expert reported that no consistent changes were seen in the kidneys and the renal effects were not secondary to treatment.
Justification for classification or non-classification
Based on the PFBS data cited in the Existing Chemical Hazard Assessment Report by the Australian Government, Department of Health and Ageing, NICNAS, November 2005, a classification is not justified.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
